MedTrace Logo

A Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation

NCT04269876 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2023-01-13

No results posted yet for this study

Summary

To assess the efficacy and safety of a Marine Lipid Oil Concentrate formulation on inflammatory biomarkers and overall well-being in male and female subjects who are overweight to mildly obese, but otherwise generally healthy.

Conditions

Interventions

DIETARY_SUPPLEMENT

Marine Lipid Oil Concentrate

Marine Lipid Oil Concentrate softgels

DIETARY_SUPPLEMENT

Dietary Supplement

Dietary Supplement capsules

DIETARY_SUPPLEMENT

Placebo

Placebo softgels

DIETARY_SUPPLEMENT

Placebo

Placebo capsules

Sponsors & Collaborators

  • Supplement Formulators, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Swick, Ph.D · LIfe Extension

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04269876 on ClinicalTrials.gov